Atherosclerosis
Atherosclerosis(动脉粥样硬化)
Atherosclerosis 相关产品(86)
- GC18241LysophosphatidylcholinesCAS: 9008-30-4纯度: >98.00% / >99.00%
Lysophosphatidylcholines是一类重要的磷脂分子，是磷脂酶A2水解磷脂酰胆碱的产物。
- GC18522Phosphatidylserines (sodium salt)CAS: 383908-63-2纯度: >95.00%
A mixture of phosphatidylserines isolated from soy
- GC18616MMP-8 Inhibitor ICAS: 236403-25-1纯度: >95.00% / >98.00%
MMP-8 Inhibitor I是一种强效的基质金属蛋白酶-8（MMP-8）抑制剂，但口服生物利用度较低。
- GC19433Cholesteryl HeptadecanoateCAS: 24365-37-5纯度: >97.00%
An internal standard for quantification of cholesterol esters
- GC33760ETC-1002 (ESP-55016)CAS: 738606-46-7纯度: >98.00%
ETC-1002 (ESP-55016) 是一种新型的每日一次口服降脂药物，可抑制腺苷三磷酸柠檬酸裂解酶（ACL），一种胆固醇合成途径中的酶，并导致低密度脂蛋白胆固醇（LDL）受体的上调，半衰期在15到24小时之间。
- GC400535α,6α-epoxy CholestanolCAS: 1250-95-9纯度: >95.00%
5α,6α-epoxy Cholestanol 是一种胆固醇衍生物，可以通过线粒体中的细胞色素P450酶系催化生成或是在脂质过氧化过程中诱导生成，可调节胆汁酸的生物合成、诱导肿瘤细胞的分化和死亡。
- GC402027α-hydroxy Cholesterol-d7CAS: 349553-94-2纯度: >99.00%
An internal standard for the quantification of 7α-hydroxy cholesterol
- GC40203Cholesterol-d6CAS: 60816-17-3纯度: >99.00%
An internal standard for the quantification of cholesterol
- GC404185β,6β-epoxy CholestanolCAS: 4025-59-6纯度: >95.00%
An oxidative metabolite of cholesterol
- GC41649(±)13-HODE cholesteryl esterCAS: 167354-91-8纯度: >98.00%
A 15-LO product derived from cholesteryl linoleate
- GC41666(±)9-HODE cholesteryl esterCAS: 33783-76-5纯度: >98.00%
A racemic monohydroxy fatty acid cholesteryl ester
- GC4189313(R)-HODE cholesteryl esterCAS: 330800-94-7纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
- GC4189513(S)-HODE cholesteryl esterCAS: 141554-21-4纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
- GC426349(R)-HODE cholesteryl esterCAS: 330800-93-6纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
- GC426359(S)-HODE cholesteryl esterCAS: 143442-54-0纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18241 | Lysophosphatidylcholines | 9008-30-4 | >98.00% / >99.00% | |
Lysophosphatidylcholines是一类重要的磷脂分子，是磷脂酶A2水解磷脂酰胆碱的产物。 | ||||
| GC18522 | Phosphatidylserines (sodium salt) | 383908-63-2 | >95.00% | |
A mixture of phosphatidylserines isolated from soy | ||||
| GC18616 | MMP-8 Inhibitor I | 236403-25-1 | >95.00% / >98.00% | |
MMP-8 Inhibitor I是一种强效的基质金属蛋白酶-8（MMP-8）抑制剂，但口服生物利用度较低。 | ||||
| GC18788 | Graphislactone A | 52179-44-9 | - | |
An antioxidant | ||||
| GC19433 | Cholesteryl Heptadecanoate | 24365-37-5 | >97.00% | |
An internal standard for quantification of cholesterol esters | ||||
| GC19460 | 9(S)-HODE | 73543-67-6 | >98.00% | |
A lipoxygenase product of linoleic acid | ||||
| GC33760 | ETC-1002 (ESP-55016) | 738606-46-7 | >98.00% | |
ETC-1002 (ESP-55016) 是一种新型的每日一次口服降脂药物，可抑制腺苷三磷酸柠檬酸裂解酶（ACL），一种胆固醇合成途径中的酶，并导致低密度脂蛋白胆固醇（LDL）受体的上调，半衰期在15到24小时之间。 | ||||
| GC40053 | 5α,6α-epoxy Cholestanol | 1250-95-9 | >95.00% | |
5α,6α-epoxy Cholestanol 是一种胆固醇衍生物，可以通过线粒体中的细胞色素P450酶系催化生成或是在脂质过氧化过程中诱导生成，可调节胆汁酸的生物合成、诱导肿瘤细胞的分化和死亡。 | ||||
| GC40142 | Lactosylceramides (bovine buttermilk) | 4682-48-8 | >98.00% | |
A sphingolipid | ||||
| GC40202 | 7α-hydroxy Cholesterol-d7 | 349553-94-2 | >99.00% | |
An internal standard for the quantification of 7α-hydroxy cholesterol | ||||
| GC40203 | Cholesterol-d6 | 60816-17-3 | >99.00% | |
An internal standard for the quantification of cholesterol | ||||
| GC40418 | 5β,6β-epoxy Cholestanol | 4025-59-6 | >95.00% | |
An oxidative metabolite of cholesterol | ||||
| GC40467 | (±)11-HETE | 73804-65-6 | >98.00% | |
A non-enzymatically derived oxylipin | ||||
| GC40624 | MMP-3 Inhibitor VIII | 208663-26-7 | >95.00% | |
A selective inhibitor of MMP-3 | ||||
| GC41614 | 24-dehydro Cholesterol | 313-04-2 | >98.00% | |
An immediate precursor of cholesterol | ||||
| GC41636 | CAY10487 | 778624-05-8 | >98.00% | |
An antioxidant with anti-atherogenic activity | ||||
| GC41649 | (±)13-HODE cholesteryl ester | 167354-91-8 | >98.00% | |
A 15-LO product derived from cholesteryl linoleate | ||||
| GC41666 | (±)9-HODE cholesteryl ester | 33783-76-5 | >98.00% | |
A racemic monohydroxy fatty acid cholesteryl ester | ||||
| GC41893 | 13(R)-HODE cholesteryl ester | 330800-94-7 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||
| GC41895 | 13(S)-HODE cholesteryl ester | 141554-21-4 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||
| GC41897 | 13(S)-HOTrE | 87984-82-5 | >98.00% | |
A 15-LO product derived from GLA | ||||
| GC42411 | 4-hydroxy Nonenal Alkyne | 1011268-23-7 | >98.00% | |
4-HNE modified for click chemistry | ||||
| GC42634 | 9(R)-HODE cholesteryl ester | 330800-93-6 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||
| GC42635 | 9(S)-HODE cholesteryl ester | 143442-54-0 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||